The pharmacokinetic characteristics of tocainide:

Oral bioavailability Onset of action Peak response Duration of action Plasma half-life

Approximately 100% Not known 0.5-2 hours 8 hours 15 hours

Primary route of metabolism Primary route of excretion Therapeutic serum

Clinical Uses


Renal (40% unchanged) 3-11 ^g /mL concentration

Tocainide is indicated for the treatment of symptomatic ventricular arrhythmias refractory to more conventional therapy. Serious noncardiac adverse effects limit its use to patients with life-threatening arrhythmias.

Diabetes Sustenance

Diabetes Sustenance

Get All The Support And Guidance You Need To Be A Success At Dealing With Diabetes The Healthy Way. This Book Is One Of The Most Valuable Resources In The World When It Comes To Learning How Nutritional Supplements Can Control Sugar Levels.

Get My Free Ebook

Post a comment